JDRF Blog

Back to school season during the coronavirus pandemic has been met with several challenges, but for college students, preparation is still key, whether on-campus or at home.

JDRF welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options for people in the Medicare program.

Leading researchers from around the world will gather for the annual meeting of the European Association for the Study of Diabetes (EASD)....

The common belief for decades was that diligent monitoring of blood sugars and intensive insulin therapy had little consequence for people with...

Four fearless female leaders for JDRF who emulate the Veronica Beard brand share how JDRF has made a difference for the T1D community

In the words of Colin Dayan, M.D., Ph.D., professor of clinical diabetes and metabolism at Cardiff University: “Type 1 diabetes is almost the only major autoimmune disease now that does not have a licensed immunotherapy.” And he’s going to change that.

Accurate control of blood sugar for people with type 1 diabetes (T1D) was not easy in the 1970s. At the time, the...